Abstract:Drug‐like molecules are found by either expanding the set of molecules with known properties by selecting molecules from database and performing calculations on them or exploring the drug‐like chemical space by generating them from scratch using generative models. This review article highlights modern machine learning based methods that try to efficiently enhance our sampling capability beyond conventional screening methods. Drug design involves the process of identifying and designing novel molecules that have desirable properties and bind well to a given target receptor. Typically, such molecules are identified by screening large chemical libraries for desirable physicochemical properties and binding strength with the target protein. This traditional approach, however, has severe limitations as exhaustively screening every molecule in known chemical libraries is computationally infeasible. Furthermore, currently available molecular libraries are only a minuscule part of the entire set of possible drug‐like molecular structures (drug‐like chemical space). In this review, we discuss how the former limitation is addressed by modeling virtual screening as a search space problem and how these endeavors utilize machine learning to reduce the number of required computational experiments to identify top candidates. We follow that up by discussing generative methods that attempt to approximate the entire drug‐like chemical space providing us a path to explore beyond the known drug‐like chemical space. We place special emphasis on generative models that learn the marginal distributions conditioned on specific properties or receptor structures for efficient sampling of molecules. Through this review, we aim to highlight modern machine learning based methods that try to efficiently enhance our sampling capability beyond conventional screening methods which, in turn, would benefit drug design significantly. Therefore, we also encourage further methods of development that work on such important aspects of drug design. This article is categorized under: Data Science > Chemoinformatics Data Science > Artificial Intelligence/Machine Learning Data Science > Computer Algorithms and Programming

Few-Shot Learning for Low-Data Drug Discovery

Low Data Drug Discovery with One-Shot Learning

Deep learning for low-data drug discovery: hurdles and opportunities

Advancing Drug Discovery with Deep Learning: Harnessing Reinforcement Learning and One-Shot Learning for Molecular Design in Low-Data Situations

Traversing Chemical Space with Active Deep Learning: A Computational Framework for Low-data Drug Discovery

Novel Big Data-Driven Machine Learning Models for Drug Discovery Application

Deep Learning in Virtual Screening: Recent Applications and Developments

Meta Learning With Graph Attention Networks for Low-Data Drug Discovery

Meta-learning Approaches for Few-Shot Learning: A Survey of Recent Advances

Deep Learning and Virtual Drug Screening

Transfer Learning for Drug Discovery

Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening

Context-enriched molecule representations improve few-shot drug discovery

Enhanced Sampling of Chemical Space for High Throughput Screening Applications using Machine Learning

Developing a Semi-Supervised Approach Using a PU-Learning-Based Data Augmentation Strategy for Multitarget Drug Discovery

Efficient and enhanced sampling of drug‐like chemical space for virtual screening and molecular design using modern machine learning methods

The Goldilocks paradigm: comparing classical machine learning, large language models, and few-shot learning for drug discovery applications

Target-Free Compound Activity Prediction via Few-Shot Learning

Novel prediction methods for virtual drug screening

Lessons learnt from machine learning in early stages of drug discovery

Augmenting Hit Identification by Virtual Screening Techniques in Small Molecule Drug Discovery